Oral Oncolytics and Cardiovascular Risk Management and Monitoring

*University of New Mexico College of Pharmacy, Albuquerque, NM;

†Department of Pharmacy, Billings Clinic, Billings, MT; and

‡Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Nashville, TN.

Reprints: Joel C. Marrs, PharmD, MPH, Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, 301 S. Perimeter Park Drive, Nashville, TN 37211 (e-mail: [email protected]).

The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jcvp.org).

Comments (0)

No login
gif